Compounds to treat diabetes and associated conditions
US6855732B2 · kind B2 · utility
1Cited by
45References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 2002 |
| Grant date | Feb 15, 2005 |
| Priority date | — |
| Expiry date | Feb 15, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds are provided that lower blood glucose concentrations, lower serum triglyceride concentrations, lower systolic blood pressure, and increase glucose uptake by adipose tissue, but do not affect the expression of PPAR-γ by adipose tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.